Probiomed has been acquired by Sanfer
May 2022 — The shareholders of Probiomed S.A. de C.V. have sold the company to Laboratorios Sanfer.
Probiomed was founded in 1970 and is a vertically integrated developer, manufacturer and marketer of pharmaceutical and biopharmaceutical products. The company has three production plants and one of the most advanced R&D platforms in the region. The R&D team has 46 engineers who have developed and launched over 120 products, 14 of which were biopharmaceuticals.
Sanfer, with over 80 years of history, is one of the leading companies in the Mexican pharmaceutical market. It participates in more than 10 therapeutic areas, including infectiology, algology, cardiology, gastroenterology, central nervous system, metabolic syndrome, gynecology, urology, oncology, over-the-counter products and animal health products for all types of species.
Our role in the transaction
Oaklins’ team in Mexico acted as the financial advisor to Probiomed in the debt restructuring of US$120 million under Chapter 11 “Concurso Mercantil” in Mexico, as well as in the structuring of the acquisition by Sanfer, resulting in an equity injection of US$30 million.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Nymann Kloak- & Miljøservice has been acquired by Serwent Group
Nymann Kloak- & Miljøservice has been acquired by Serwent Group. The acquisition expands Serwent’s footprint in Denmark while broadening its service offering and strengthening capacity across its existing platform. This transaction further supports Serwent’s ambition to become the leading Nordic operator in underground infrastructure maintenance.
Conozca másHeka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.
Conozca másGP-Connect has joined forces with Transformation Capital to accelerate growth
Transformation Capital, a Netherlands-based investment firm, has joined forces with GP-Connect, a leading international secondment platform with specialized brands serving the hospitality, IT, skilled labor, technical services and dental sectors. As part of the transaction, GP-Connect welcomes Transformation Capital as its new shareholder to support the company’s next phase of growth, while the founders and existing shareholders will remain actively involved. The partnership will focus on executing a targeted buy-and-build strategy, expanding the business internationally and further strengthening GP-Connect’s portfolio.
Conozca más